The effect of hepatitis C treatment and human immunodeficiency virus (VIH) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam

Ítems similars

• THE IMPACT OF BEHAVIOURAL CHANGES ON THE PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS C AMONG INJECTING DRUG USERS
  per: MURRAY, J.M
• HEPATITIS C VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS-1 CO-INFECTION IN FORMER HEROIN ADDICTS IN METHADONE MAINTENANCE TREATMENT
  per: PICCOLO, P.
• CAN HEPATITIS C VIRUS PREVALENCE BE USED AS A MEASURE OF INJECTION-RELATED HUMAN IMMUNODEFICIENCY VIRUS RISK IN POPULATIONS OF INJECTING DRUG USERS?. AN ECOLOGICAL ANALYSIS
  per: VICKERMAN, P.
• HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS C VIRUS TESTING SERVICES AT SYRINGE EXCHANGE PROGRAMS: AVAILABILITY AND OUTCOMES
  per: HEINZERLING, K.G
• HEPATITIS C VIRUS TRANSMISSION DYNAMICS IN INJECTION DRUG USERS
  per: HAGAN, H.